Sr. Operational Excellence Engineer

Sr. Operational Excellence Engineer Employer Legend Biotech Location Raritan, New Jersey Salary $142146

• $186567 Start date Mar 20, 2026 categoriesView less categories Job Details Company Job Details Legend Biotech is a global biotechnology company dedicated to treating, and one day curing, life-threatening diseases.

Headquartered in Somerset, New Jersey, we are developing advanced cell therapies across a diverse array of technology platforms, including autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R D sites around the world, we apply these innovative technologies to pursue the discovery of safe, efficacious and cutting-edge therapeutics for patients worldwide. Legend Biotech entered into a global collaboration agreement with Janssen, one of the pharmaceutical companies of Johnson & Johnson, to jointly develop and commercialize ciltacabtagene autolecuel (cilta-cel). Our strategic partnership is designed to combine the strengths and expertise of both companies to advance the promise of an immunotherapy in the treatment of multiple myeloma. Legend Biotech is seeking a Sr. Operational Excellence Engineer as part of the Technical Operations team based in Raritan, NJ. Role Overview This position will be responsible for driving the operational excellence / continuous improvement program at the Raritan cGMP Clinical and Commercial Cell Therapy Manufacturing plant. This individual will lead complex, cross-functional continuous improvement projects with support from various site functions to support strategic and tactical objectives. The individual will be responsible for owning, driving and delivering safety, quality, delivery and cost saving and/or efficiency improvements, ensuring alignment in support of the overall objectives and priorities of the plant. The role will require demonstrated lean leadership, expertise in disciplined problem solving and effective continuous improvement in a cGMP environment. This is a highly visible role requiring communication, coordination and collaboration across cross functional partners and with site leadership. This role will report to the Lead, Operational Excellence Execution. Key Responsibilities

• Responsible for identifying and, with the support of functional areas and the Operational Excellence team, executing on a Lean and Continuous Improvement strategy that enables the site to achieve it's SQPDC objectives.
• Executes the defined continuous improvement program through the use of lean and six sigma methodologies such as DMAIC, root cause problem solving, daily management system (tier process), leader standard and standardized work, visual tools, PDCA, Kanban, pull systems, SMED, pareto, FMEA, A3 thinking, time studies, poke yoke, value stream/process mapping and others.
• Reports progress updates of programs and projects to various levels of leadership and key stakeholders.
• Operates as the Lean Coach for the Raritan site, mentoring Lean Practitioners and leadership to adopt a continuous improvement mindset.
• Leads, facilitates and teaches others to facilitate and participate in kaizen events and increase continuous improvement skills.
• Applies and teaches change management methodology in all aspects of the plant operational excellence efforts. Requirements
• B.S. in STEM related field required. M.S. in STEM related field preferred or desirable.
• Minimum 10+ years of experience with a B.S. or 8+ years of experience with a M.S leading and supporting continuous improvement efforts and/or Kaizen programs in a manufacturing environment.
• Driven to completion numerous quantifiable, improvements in SQPDC pillars within multiple site functions (Production, Engineering, Facilities, Maintenance, QA, QC, etc.).
• Trained in lean and six sigma methodologies required. Six Sigma Black Belt (with projects) preferred. Certification by reputable 3rd party organizations (i.e. ASQ, Society of Manufacturing Engineers) preferred.
• Routine application of Lean and Six Sigma problem solving tools and techniques to drive substantial business results.
• Superior knowledge and demonstrated execution of continuous improvement and lean tools and techniques.
• Proficiency in Change Management and Communication in a highly matrixed environment.
• Advanced Proficiency with Excel
• Pivot Tables, etc.
• Proficiency with Process Mapping Software
• Visio, etc.
• Advanced Proficiency with statistics and data analysis in a manufacturing setting and Statistical Analysis Software
• Minitab , JMP, etc.

#Li-BZ1 #Li-Onsite The base pay range below is what Legend Biotech USA Inc. reasonably expects to offer at the time of posting. Actual compensation may vary based on experience, skills, qualifications, and geographic location. The company reserves the right to modify this range as needed and in accordance with applicable laws.

Other Types of Pay:

Performance-based bonus and/or equity is available to employees in eligible roles.

Benefits and Paid Time Off:

Medical, dental, and vision insurance as well as a 401(k) retirement plan with a company match that vests fully on day one. We offer eight (8) weeks of paid parental leave after just three (3) months of employment, and a paid time off policy that includes vacation time, personal time, sick time, floating holidays, and eleven (11) company holidays. Additional voluntary benefits include flexible spending and health savings accounts, life and AD&D insurance, short

• and long-term disability coverage, legal assistance, and supplemental plans such as pet, critical illness, accident, and hospital indemnity insurance.

We also provide voluntary commuter benefits, family planning and care resources, well-being initiatives, and peer-to-peer recognition programs; demonstrating our ongoing commitment to building a culture where our people feel empowered, supported, and inspired to do their best work. Pay Range (Base Pay): $142,146

• $186,567 USD Please note: These benefits are offered exclusively to permanent full-time employees.

Contractors are not eligible for benefits through Legend Biotech. EEO Statement It is the policy of Legend Biotech to provide equal employment opportunities without regard to actual or perceived race, color, creed, religion, national origin, ancestry, citizenship status, age, sex or gender (including pregnancy, childbirth, related medical conditions and lactation), gender identity or gender expression (including transgender status), sexual orientation, marital status, military service and veteran status, disability, genetic information, or any other protected characteristic under applicable federal, state or local laws or ordinances. Employment is at-will and may be terminated at any time with or without cause or notice by the employee or the company. For information related to our privacy notice, please review: Legend Biotech Privacy Notice. Company Legend Biotech was founded as an early-stage cell therapy company in 2014. The company was the brainchild of visionary scientists who recognized that antibody-based therapeutics could potentially treat disease and possessed the backgrounds in immunology and gene editing to take the leap. For two years, Legend Biotech, then known as the "Legend Project," operated in a room the size of a freight elevator, with the goal of creating a cell therapy for multiple myeloma, a hematological cancer that often relapses and can become refractory. The team produced nanobodies for single-domain antibody drugs and ultimately extended the half-life of the nanobodies with proprietary technologies. In 2015, Legend's scientists focused on research for chimeric antigen-receptor T-cells (CAR-T) targeting the BCMA protein, making the biotech one of the first companies in the world to engineer CAR-T cells for the BCMA protein. In 2016, investigator-initiated trials began in China. In 2017, data from the trials were presented at the American Society for Clinical Oncology (ASCO), which led to a partnership with biopharmaceutical company Janssen Biotech, Inc. to co-develop the anti-BCMA CAR-T, ciltacabtagene autoleucel (cilta-cel). Applications seeking approval of cilta-cel for the treatment of patients with RRMM are currently under regulatory review by several health authorities around the world.

CARVYKTI

™ (ciltacabtagene autoleucel) was approved by the U.S. Food and Drug Administration in February 2022 and received conditional marketing approval from the European Medicines Agency in May 2022. Today Legend Biotech is a global, commercial-stage company driven by a passion for patients. We continue to build our pipeline of cell therapy platforms, which includes CAR-T, CAR-NK, CAR-γδ T and non-gene-editing CAR technologies. Our goal is to bring hope and opportunity to patients and their families by continuing to explore unique technologies. Company info Location Somerset New Jersey United States